Ken Griffin Bria Cell Therapeutics Corp. Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
Shares
1 transactions
Others Institutions Holding BCTX
# of Institutions
1Shares Held
1Call Options Held
0Put Options Held
0About BriaCell Therapeutics Corp.
- Ticker BCTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,518,000
- Market Cap $8.38M
- Description
- BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and...